Why this team?

Why this team?

Biology + AI + FDA wins

Biology + AI + FDA wins

A rare combination of expertise in biology and AI, experienced in both pharmaceutical and device products requiring substantial FDA Approval.

Andrew J. Buckler, PhD

Andrew J. Buckler, PhD

Andrew J. Buckler, PhD

Founder and Chief Executive Officer

Founder and Chief Executive Officer

Founder and Chief Executive Officer

Executive and scientist and serial entrepreneur

Multidisciplinarian at the intersection of cardiovascular biology, AI/ML, and systems pharmacology

Founder of Elucid, funded at $100M+ to phenotype CVD

>70 peer reviewed publications and > 50 issued patents

Dr. Gregg W. Stone, MD, FACC, FSCAI

Dr. Gregg W. Stone, MD, FACC, FSCAI

Dr. Gregg W. Stone, MD, FACC, FSCAI

Founding Partner and Chair, MAB

Founding Partner and Chair, MAB

Founding Partner and Chair, MAB

Cardiologist and Dir of Acad Affairs for Mt Sinai Heart and Prof. Med, Icahn School of Medicine

PI for 150+ trials, 3000+ pubs, 1000s invited lectures.

H-index of 206, top 0.01% of cited on Web of Science.

Expert on drug-eluting stents and bioresorbable scaffolds

Dr. Brajesh Lal, MD, MBBS, FACS

Dr. Brajesh Lal, MD, MBBS, FACS

Chief of Vascular Surgery, UMMC, Mayo, and VA. Co-chair of CREST-2

Dr. Ulf Hedin, MD PhD

Dr. Ulf Hedin, MD PhD

Prof Vascular Surgery and Molecular Medicine, KI (Stockholm). PI of BiKE.

Dr. David Erlinge, MD PhD

Dr. David Erlinge, MD PhD

Head of Cardiology, Skane U (Lund) and Leader of CV trials inc. SCAPIS

Dr. Patrick Serruys, MD PhD

Dr. Patrick Serruys, MD PhD

Prof Interventional Cardiology and Innovation, NUI and Imperial (London)

Clint Miller, PhD

Clint Miller, PhD

Functional genomics of complex cardiovascular diseases, Stanford and UVA

Ian Kemp MBA MSF

Ian Kemp MBA MSF

Founding Partner and Chief Business Officer

Dr. Brajesh Lal, MD, MBBS, FACS

Chief of Vascular Surgery, UMMC, Mayo, and VA. Co-chair of CREST-2

Dr. Ulf Hedin, MD PhD

Prof Vascular Surgery and Molecular Medicine, KI (Stockholm). PI of BiKE.

Dr. David Erlinge, MD PhD

Head of Cardiology, Skane U (Lund) and Leader of CV trials inc. SCAPIS

Dr. Patrick Serruys, MD PhD

Prof Interventional Cardiology and Innovation, NUI and Imperial (London)

Clint Miller, PhD

Functional genomics of complex cardiovascular diseases, Stanford and UVA

Ian Kemp MBA MSF

Founding Partner and Chief Business Officer

Let’s shape the future of cardiovascular health

Let’s shape the future of cardiovascular health

© 2025 Vascentis.